Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

G. Schellack; Johanna Catharina Meyer; Natalie Schellack

Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

G. Schellack
, Johanna Catharina Meyer
, Natalie Schellack^*

^*Corresponding author for this work

Research output: Contribution to journal › Literature review › peer-review

Abstract

© 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.

Original language	English
Pages (from-to)	18-24
Number of pages	7
Journal	South African Family Practice
Volume	58
Issue number	2
Publication status	Published - 1 Jan 2016

Keywords

Cost-effectiveness
GORD
Gastro-oesophageal reflux
PPIs
Proton-pump inhibitors

Cite this

@article{b7e53125809143f483dcf4a64a5078d4,

title = "Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options: An overview of the cost-effectiveness of pharmacotherapeutic treatment options",

abstract = "{\textcopyright} 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.",

keywords = "Cost-effectiveness, GORD, Gastro-oesophageal reflux, PPIs, Proton-pump inhibitors",

author = "G. Schellack and Meyer, \{Johanna Catharina\} and Natalie Schellack",

year = "2016",

month = jan,

day = "1",

language = "English",

volume = "58",

pages = "18--24",

journal = "South African Family Practice",

issn = "2078-6190",

publisher = "AOSIS (Pty) Ltd",

number = "2",

}

Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options: An overview of the cost-effectiveness of pharmacotherapeutic treatment options. / Schellack, G.; Meyer, Johanna Catharina; Schellack, Natalie.
In: South African Family Practice, Vol. 58, No. 2, 01.01.2016, p. 18-24.

Research output: Contribution to journal › Literature review › peer-review

TY - JOUR

T1 - Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

T2 - An overview of the cost-effectiveness of pharmacotherapeutic treatment options

AU - Schellack, G.

AU - Meyer, Johanna Catharina

AU - Schellack, Natalie

PY - 2016/1/1

Y1 - 2016/1/1

N2 - © 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.

AB - © 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.

KW - Cost-effectiveness

KW - GORD

KW - Gastro-oesophageal reflux

KW - PPIs

KW - Proton-pump inhibitors

UR - https://www.scopus.com/pages/publications/84978997442

M3 - Literature review

SN - 2078-6190

VL - 58

SP - 18

EP - 24

JO - South African Family Practice

JF - South African Family Practice

IS - 2

ER -

Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

Abstract

Keywords

Other files and links

Fingerprint

Cite this